Daily non-political popular news in brief.

Systems Biology poised to revolutionize the understanding of cell function and disease

09-07-2007 · EurekAlert!

Systems Biology is transforming the way scientists think about biology and disease. This novel approach to research could prompt a shake up in medical science and it might ultimately allow clinicians to predict and treat complex diseases such as diabetes, heart failure, cancer and metabolic syndrome for which there are currently no cures.

Keywords: systems, biology, poised, revolutionize, understanding, cell, function, disease, system

« Previous | Next »

Similar news on "Systems Biology poised to revolutionize the understanding of cell function and disease":

Researchers in Montréal and the US create model of key immune-system component
12-08-2006 · EurekAlert!
Researchers at Université de Montréal, working with teams at Massachusetts General Hospital and Johns Hopkins University, have made a major breakthrough in understanding an essential aspect of the immune system. For the first time, using a systems biology approach, they have developed a model that facilitates the study of the function of the phagosome. The results of their study were published this week in the prestigious journal Nature.
Similar news · Read more »
BERT tells ERNI it's time to grow a brain
01-08-2008 · EurekAlert!
UCL scientists have discovered how two proteins called BERT and ERNI interact in embryos to control when different organ systems in the body start to form, deepening our understanding of the development of the brain and nervous system and stem cell behaviour.
Similar news · Read more »
New mechanism for nutrient uptake discovered
02-11-2007 · EurekAlert!
Biologists at the Carnegie Institution's Department of Plant Biology have discovered a new way that plant cells govern nutrient regulation—neighboring pore-like structures at the cell’s surface physically interact to control the uptake of a vital nutrient, nitrogen. It is the first time scientists have found that the interaction of neighboring molecules is essential to this regulation. The discovery has widespread potential -- from understanding human diseases, such as kidney function, to engineering better crops.
Similar news · Read more »
New proteomics research promises to revolutionize biomedical discovery
07-19-2007 · EurekAlert!
In a research article that will be published in the July 20 issue of the journal Molecular Cell, a research team led by Dr. Benoit Coulombe from the Institut de recherches clniques de Montréal describes a powerful proteomics approach that promises to have a profound impact on our current understanding of the human proteome, and the function of its individual proteins.
Similar news · Read more »
A dynamical systems hypothesis of schizophrenia
11-08-2007 · EurekAlert!
The inconsistent expressions related to schizophrenia are newly structured in a recent study by researchers at the Universitas Pompeau Fabra and Oxford University. Marco Loh, Edmund Rolls and Gustavo Deco have created a dynamical system framework to discuss the disorder, publishing on Nov. 9, 2007 in the journal PLoS Computational Biology. The dynamical framework put forth in this study may better the understanding of the symptoms of schizophrenia, therefore culminating in better treatment for those with the disorder.
Similar news · Read more »
Pittsburgh-based team engineers muscle, bone cell differentiation with aid of ink-jet printer
12-10-2006 · EurekAlert!
A team of researchers from Carnegie Mellon University and the University of Pittsburgh has created and used an innovative ink-jet system to print "bio-ink" patterns that direct muscle-derived stem cells from adult mice to differentiate into both muscle cells and bone cells. The results, which could revolutionize the design of replacement body tissues, will be presented Sunday, Dec. 10 at the 46th annual meeting of the American Society for Cell Biology in San Diego.
Similar news · Read more »
Parkinson's protein protects neurons from stress induced cell death
05-21-2007 · EurekAlert!
Parkinson's disease, also known as shaking palsy, is one of the most frequent diseases of the nervous system. In a collaborative effort the groups of Dr. Konstanze Winklhofer (Ludwig-Maximilians-University Munich) and Dr. Daniel Krappmann (GSF -- Research Center for Environment and Health, Neuherberg) have now been able to reveal a novel function for the Parkin protein.
Similar news · Read more »
Transplanting human gut bugs into mice helps understanding of metabolic system
05-21-2007 · EurekAlert!
Bugs found in the guts of humans, which play an important part in people’s metabolic makeup, have been transplanted into mice to further understanding of the human and animal metabolic system, reveals a new study in the journal Molecular Systems Biology. Bugs in the gut live symbiotically in human and animal bodies.
Similar news · Read more »
Insights into cell movement likely to aid immune study, cancer research
01-07-2008 · EurekAlert!
Scientists at Washington University School of Medicine in St. Louis have used yeast cells to better understand a collection of proteins associated with the formation of actin networks, which are essential to cell movement. The cell's ability to move is important to a broad range of biomedical concerns, including understanding how immune system cells pursue disease-causing invaders and how metastasizing cancer cells migrate from a tumor.
Similar news · Read more »
Advance in understanding of blood pressure gene could lead to new treatments
02-04-2007 · EurekAlert!
Research by scientists at UCL (University College London) has clearly demonstrated for the first time the structure and function of a gene crucial to the regulation of blood pressure. The discovery could be important in the search for new treatments for illnesses such as heart disease, the UK's biggest killer. In a paper published online today in Nature Medicine, the team, led by Professor Patrick Vallance and Dr James Leiper, UCL Department of Medicine, reveal the role of the human gene dimethylarginine dimethylaminohydrolase (DDAH), showing that loss of DDAH activity disrupts nitric oxide (NO) production. NO is critical in the regulation of blood pressure, nervous system functions and the immune system. The role of DDAH is to break down modified amino acids (Asymmetric dimethylarginine (ADMA) and monomethyl arginine (L-NMMA)) that are produced by the body and have been shown to inhibit NO synthase. These molecules accumulate in various disease states including diabetes, renal failure and pulmonary and systemic hypertension, and their concentration in plasma (the fluid component of blood) is strongly predicative of cardiovascular disease and death. In a healthy human body, the majority of ADMA is eliminated through active metabolism by DDAH. Scientists have hypothesised that if DDAH function is impaired, NO production is reduced, and that this could be an important feature of increased cardiovascular risk. To examine this pathway in more detail, the researchers deleted the DDAH gene in mice. These mice went on to develop hypertension, or high blood pressure. They also designed specific inhibitors (small molecules) which bind to the active site of human DDAH. These small molecule inhibitors also induced hypertension in mice, confirming the importance of DDAH in the regulation of blood pressure. Dr Leiper, UCL Medicine, said: “These genetic and chemical approaches to disrupt DDAH showed remarkably consistent results, and provide compelling evidence that loss of DDAH function increases the concentration of ADMA and thereby disrupts vascular NO signalling. “There has been considerable scientific interest in this pathway and the role of ADMA as a novel risk factor, but so far there's been little evidence to support the idea that it's a cause of disease, rather than just a marker. Genes and their pathways are crucial to our understanding of cardiovascular disease and a better understanding of DDAH-1 could lead to important new treatments. “It could help us to establish if genetic variation predisposes certain people to these diseases, or whether environmental factors exert some of their effects through modulation of DDAH activity. “Our research also shows that this pathway could be harnessed therapeutically to limit production of NO in certain situations where too much nitric oxide is a bad thing; for example, hypotension and septic shock. These are some of the biggest problems in intensive care medicine and there is a huge unmet need for drug treatments.” The study, which was carried out at UCL's Rayne Institute, was funded by grants from the British Heart Foundation, the Wellcome Trust and the Medical Research Council. Professor Jeremy Pearson, Associate Medical Director of the British Heart Foundation, said: "The unexpected finding in the 1980s that a simple gas, nitric oxide (NO), is made by cells in the blood vessel wall and is a powerful control of blood vessel relaxation led to the award of the Nobel Prize in 1998 to its discoverers. "More recently, there has been increasing evidence that impairment of NO production is likely to be an important factor in the development of heart and circulatory disease, but the mechanisms responsible are not fully understood. "This study suggests for the first time that the loss of the activity of the enzyme DDAH-1 leads to reduced NO production and may cause heart and circulatory disease. These findings are likely to be important in the search for new ways to optimise the health of our blood vessels." ### Notes for Editors 1. For more information, please contact Ruth Metcalfe in the UCL Media Relations Office on tel: +44 (0)20 7679 9739, mobile: +44 (0)7990 675 947, out of hours: +44 (0)7917 271 364, e-mail: r.metcalfe@ucl.ac.uk2. 'Disruption of methylarginine metabolism impairs vascular homeostasis' is published in the February issue of the journal Nature Medicine. Advance online publication is embargoed to 18.00 GMT (13.00 US Eastern) Sunday 4 February 2007. Journalists can obtain copies of the paper by contacting the UCL Media Relations Office.3. The study was funded by the British Heart Foundation, the Wellcome Trust and the Medical Research Council. About UCL Founded in 1826, UCL was the first English university established after Oxford and Cambridge, the first to admit students regardless of race, class, religion or gender, and the first to provide systematic teaching of law, architecture and medicine. In the government's most recent Research Assessment Exercise, 59 UCL departments achieved top ratings of 5* and 5, indicating research quality of international excellence. UCL is the fourth-ranked UK university in the 2006 league table of the top 500 world universities produced by the Shanghai Jiao Tong University. UCL alumni include Mahatma Gandhi (Laws 1889, Indian political and spiritual leader); Jonathan Dimbleby (Philosophy 1969, writer and television presenter); Junichiro Koizumi (Economics 1969, Prime Minister of Japan); Lord Woolf (Laws 1954, Lord Chief Justice of England & Wales); Alexander Graham Bell (Phonetics 1860s, inventor of the telephone), and members of the band Coldplay.
Similar news · Read more »